The BMJ: BioNTech Consultancy Sought to Undermine WHO Efforts to Create African mRNA Vaccine Tech Hub 10/02/2022 Editorial team A Maltese-based foundation representing BioNTech, the German company that co-produced with Pfizer a highly successful mRNA COVID vaccine, has been accused of seeking to undermine the World Health Organization’s new initiative to promote an open-source African-based COVID vaccine manufacturing hub – while proposing to ship European-fitted mRNA vaccine facilities to Africa in sea containers as […] Continue reading -> Roche Faces Prosecution for ‘Excessive Pricing’ of Breast Cancer Drug 09/02/2022 Kerry Cullinan South Africa’s Competition Commission is pursuing prosecution against Swiss pharmaceutical giant Roche for “alleged excessive pricing” of its breast cancer treatment drug, Trastuzumab (marketed as Herceptin). It estimates that some 10,000 women were unable to get the treatment they needed between 2011 and 2019 because of Trastuzumab’s cost. It has asked the country’s Competition Tribunal […] Continue reading -> Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> Africa Has Enough COVID Test Kits – Nkengasong 04/02/2022 Paul Adepoju Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC) has told Health Policy Watch that the continent is not in short supply of COVID-19 test kits. According to him, every African country that is in need of the test supplies can get it if they want. An open letter […] Continue reading -> More Clarity on Negotiators to Take Forward WHO Pandemic ‘Instrument’ Talks 04/02/2022 Kerry Cullinan Representatives from Brazil, Egypt, Japan, Netherlands, South Africa, and Thailand are to make up the World Health Organization (WHO) Intergovernmental Negotiating Body (INB) on a future pandemic instrument, according to Knowledge Ecology International. The countries each represent a different region of the WHO, namely Africa (South Africa), the Americas, known as the Pan-American Health Organisation […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Roche Faces Prosecution for ‘Excessive Pricing’ of Breast Cancer Drug 09/02/2022 Kerry Cullinan South Africa’s Competition Commission is pursuing prosecution against Swiss pharmaceutical giant Roche for “alleged excessive pricing” of its breast cancer treatment drug, Trastuzumab (marketed as Herceptin). It estimates that some 10,000 women were unable to get the treatment they needed between 2011 and 2019 because of Trastuzumab’s cost. It has asked the country’s Competition Tribunal […] Continue reading -> Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> Africa Has Enough COVID Test Kits – Nkengasong 04/02/2022 Paul Adepoju Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC) has told Health Policy Watch that the continent is not in short supply of COVID-19 test kits. According to him, every African country that is in need of the test supplies can get it if they want. An open letter […] Continue reading -> More Clarity on Negotiators to Take Forward WHO Pandemic ‘Instrument’ Talks 04/02/2022 Kerry Cullinan Representatives from Brazil, Egypt, Japan, Netherlands, South Africa, and Thailand are to make up the World Health Organization (WHO) Intergovernmental Negotiating Body (INB) on a future pandemic instrument, according to Knowledge Ecology International. The countries each represent a different region of the WHO, namely Africa (South Africa), the Americas, known as the Pan-American Health Organisation […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two Years into COVID Pandemic, 92 % of Countries Still Face Significant Health Service Disruptions 08/02/2022 Maayan Hoffman Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading -> Africa Has Enough COVID Test Kits – Nkengasong 04/02/2022 Paul Adepoju Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC) has told Health Policy Watch that the continent is not in short supply of COVID-19 test kits. According to him, every African country that is in need of the test supplies can get it if they want. An open letter […] Continue reading -> More Clarity on Negotiators to Take Forward WHO Pandemic ‘Instrument’ Talks 04/02/2022 Kerry Cullinan Representatives from Brazil, Egypt, Japan, Netherlands, South Africa, and Thailand are to make up the World Health Organization (WHO) Intergovernmental Negotiating Body (INB) on a future pandemic instrument, according to Knowledge Ecology International. The countries each represent a different region of the WHO, namely Africa (South Africa), the Americas, known as the Pan-American Health Organisation […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Has Enough COVID Test Kits – Nkengasong 04/02/2022 Paul Adepoju Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC) has told Health Policy Watch that the continent is not in short supply of COVID-19 test kits. According to him, every African country that is in need of the test supplies can get it if they want. An open letter […] Continue reading -> More Clarity on Negotiators to Take Forward WHO Pandemic ‘Instrument’ Talks 04/02/2022 Kerry Cullinan Representatives from Brazil, Egypt, Japan, Netherlands, South Africa, and Thailand are to make up the World Health Organization (WHO) Intergovernmental Negotiating Body (INB) on a future pandemic instrument, according to Knowledge Ecology International. The countries each represent a different region of the WHO, namely Africa (South Africa), the Americas, known as the Pan-American Health Organisation […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Clarity on Negotiators to Take Forward WHO Pandemic ‘Instrument’ Talks 04/02/2022 Kerry Cullinan Representatives from Brazil, Egypt, Japan, Netherlands, South Africa, and Thailand are to make up the World Health Organization (WHO) Intergovernmental Negotiating Body (INB) on a future pandemic instrument, according to Knowledge Ecology International. The countries each represent a different region of the WHO, namely Africa (South Africa), the Americas, known as the Pan-American Health Organisation […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
HIV Vaccine: Phase 1 Clinical Trial Tests mRNA Technology Against HIV 02/02/2022 Maayan Hoffman Moderna and the nonprofit science research organization IAVI have administered the first doses in a Phase I clinical trial of an experimental HIV vaccine, delivered by messenger RNA (mRNA) – the technology that revolutionized vaccines against COVID-19. The trial kicked off last week at George Washington University School of Medicine and Health Sciences in Washington, […] Continue reading -> WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO ‘Health For Peace’ Initiative Hits Crosscurrents in WHO Executive Board Debate 31/01/2022 Maayan Hoffman An innovative WHO “Health for Peace Initiative” that aims to build bridges in conflict zone and humanitarian settings through global health initiatives ran into some rough waters at last week’s Executive Board meeting – with the United States saying that it should include a human rights element – while Russia warned WHO against “politicizing” its […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> Posts navigation Older postsNewer posts